# FDA Inspection 1323460 - Bloodworks - June 18, 2026

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/bbfcf787-e31b-472a-b76e-f783b7b8070c
Source feed: FDA_Inspections

> FDA Inspection 1323460 for Bloodworks on June 18, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1323460
- Company Name: Bloodworks
- Inspection Date: 2026-06-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1159808 - 2021-12-20](https://www.keypedia.com/records/fda_inspections/bloodworks/60bca63e-1ce2-4389-8255-f7925f8088ce)
- [FDA Inspection 1159808 - 2021-12-20](https://www.keypedia.com/records/fda_inspections/bloodworks/9c151c4c-6c57-47bb-975a-3723d5b7148f)
- [FDA Inspection 1038199 - 2017-12-19](https://www.keypedia.com/records/fda_inspections/bloodworks/55f2804e-8a6c-42b0-8278-9b0235c8b72d)
- [FDA Inspection 947366 - 2015-11-02](https://www.keypedia.com/records/fda_inspections/bloodworks/5ffa3f8e-66e0-47f8-8e5d-410e55eeb97b)
- [FDA Inspection 855091 - 2013-11-05](https://www.keypedia.com/records/fda_inspections/bloodworks/511bfa7a-1718-4e4a-819a-0e2dd2a51522)

Company: https://www.keypedia.com/companies/bloodworks/7c2e814e-ef78-4453-950c-efc3faaee9d3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d